Effect of in-hospital comprehensive geriatric assessment (CGA) in older people with hip fracture : the protocol of the Trondheim Hip Fracture Trial

Background: Hip fractures in older people are associated with high morbidity, mortality, disability and reduction in quality of life. Traditionally people with hip fracture are cared for in orthopaedic departments without additional geriatric assessment. However, studies of postoperative rehabilitation indicate improved efficiency of multidisciplinary geriatric rehabilitation as compared to traditional care. This randomized controlled trial (RCT) aims to investigate whether an additional comprehensive geriatric assessment of hip fracture patients in a special orthogeriatric unit during the acute in-hospital phase may improve outcomes as compared to treatment as usual in an orthopaedic unit. Methods/design: The intervention of interest, a comprehensive geriatric assessment is compared with traditional care in an orthopaedic ward. The study includes 401 home-dwelling older persons >70 years of age, previously able to walk 10 meters and now treated for hip fracture at St. Olav Hospital, Trondheim, Norway. The participants are enrolled and randomised during the stay in the Emergency Department. Primary outcome measure is mobility measured by the Short Physical Performance Battery (SPPB) at 4 months after surgery. Secondary outcomes measured at 1, 4 and 12 months postoperatively are place of residence, activities of daily living, balance and gait, falls and fear of falling, quality of life and depressive symptoms, as well as use of health care resources and survival. Discussion: We believe that the design of the study, the randomisation procedure and outcome measurements will be of sufficient strength and quality to evaluate the impact of comprehensive geriatric assessment on mobility and other relevant outcomes in hip fracture patients

Geopolitiske virkninger av lavutslippssamfunnet

I denne rapporten presenteres hovedfunn fra ny forskning som belyser geopolitiske virkninger av overgangen til lavutslippssamfunnet og hvilke konsekvenser denne utviklingen har for Norge. Det vektlegges at en ny global klimaavtale, EUs klima- og energipolitikk, og utviklingen til noen nøkkelaktører, og i regionale og globale energimarkeder vil være sentrale påvirkningsfaktorer for Norges politikkutforming fremover. Etterspørselen etter energi globalt vil øke i takt med befolkningsvekst og velstandsutvikling, samtidig som en omfattende omstilling i den globale energisektoren vil være nødvendig for å kutte klimagassutslipp. Vi finner at en viktig drivkraft i energiomstillingsprosesser er selvforsyning av energi. Store land og energimarkeder legger stadig større vekt på selvforsyning, noe som gir Norge som energiaktør både utfordringer og nye muligheter. Nyvinninger i fornybarteknologi og desentraliserte løsninger vil gjøre nye energiløsninger mulig både i industrialiserte land og i framvoksende økonomier. Dette vil ramme Norge som olje- og gasseksportør. Lave olje- og gasspriser skaper også utfordringer for Norge de nærmeste årene. Men endringene i verdens energimarkeder skaper også nye muligheter for Norge. Ved å være en godt forberedt og omstillingsklar energiaktør som kan levere teknologiske og finansielle løsninger til land som vil øke sitt energibehov samtidig som klimagassutslippene skal ned, kan Norge bidra med løsninger til energiomstillingsprosesser i andre land og gjennom internasjonalt samarbei

Many patients with persistent pain one year after TKA report improvement by 5-7 years: A mixed methods study

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.Background: Approximately 20% of patients report pain 12 months after TKA. No studies have investigated patients’ experiences of living with persistent postsurgical pain 5 to 7 years after TKA by combining a qualitative and quantitative methodology. Question/purpose: In a mixed-methods study, we explored patients’ experiences of living with persistent pain up to 7 years after primary TKA. We asked: In a subgroup analysis of patients who reported persistent pain 1 year after TKA surgery, how do patients live with persistent pain at the 5- to 7-year postoperative timepoint? Methods: This follow-up study was part of a longitudinal study of pain, symptoms, and health-related quality of life in patients who underwent TKA for osteoarthritis. The present study targeted a subgroup of patients (22% [45 of 202]) identified in the longitudinal study who reported no improvement in pain interference with walking at 12 months after surgery. Inclusion criteria were: all 31 patients in this subgroup who attended their 5-year follow-up at the hospital and lived within a 2-hour drive from the hospital. Eight patients declined or were unable to participate due to illness or death. Hence, the final sample consisted of 23 patients (13 women and 10 men). The participants’ mean age at surgery was 66 6 10 years. There were no differences in sociodemographic baseline data between the 23 included and the 22 excluded participants. A mixed-methods approach was employed, in which the quantitative data were followed up and investigated with qualitative interviews. Instruments used were the Brief Pain Inventory preoperatively, 12 months, and 5 years after surgery, as well as a semistructured interview guide. The individual interviews were conducted at one timepoint 5 to 7 years postsurgery to capture how pain was experienced at that timepoint. The interviews were audiorecorded, transcribed, and analyzed using qualitative content analysis. Meaning units were identified, condensed, and sorted into subthemes that were interpreted and abstracted into themes, guided by the research question. With a small sample, the quantitative analysis focused on descriptive statistics and nonparametric statistics when comparing demographics of included and nonincluded patients. In addition, two multivariate mixed models for repeated measures were employed to estimate within‐patient and between‐patient variations as well as to assess the effect of time on the pain outcomes. Results: Pain with walking decreased from 12 months to 5 years postoperatively (estimated mean score 7 versus 4, difference of means -3 [95% CI -5 to -2]; p < 0.001). Pain with daily activity decreased from 12 months to 5 years postoperatively (estimated mean score 6 versus 3, difference of means -3 [95% CI -4 to -1]; p < 0.001). Pain intensity (average pain) decreased from 12 months to 5 years postoperatively (estimated mean score 5 versus 4, difference of means -1 [95% CI -3 to 0]; p = 0.03). The results are presented as point estimates rounded up to whole numbers. The qualitative data analysis yielded three themes: persistent limitations after TKA, regained wellness over time, and complexity in physical challenges. Intermittent pain with certain movements resulted in limitations with some activities in everyday life and seemed to persist beyond 5 years. Multiple painful body sites and presence of comorbidities seemed to interfere with regained wellness over time. Conclusion: In this subgroup of patients experiencing postsurgical persistent pain 12 months after primary TKA, persistent postsurgical pain still limited certain activities for the participants, although pain seemed to be less influential in their everyday lives after 5 years to 7 years. Clinicians may use these findings to inform and guide patients with delayed improvements in pain into more realistic expectations for recovery, rehabilitation, and strategies for coping with pain and impaired function. However, it is imperative to rule out other reasons for pain in patients reporting pain 12 months and longer after surgery and to be attentive of possible changes in pain over time.publishedVersio

Geopolitiske virkninger av lavutslippssamfunnet

I denne rapporten presenteres hovedfunn fra ny forskning som belyser geopolitiske virkninger av overgangen til lavutslippssamfunnet og hvilke konsekvenser denne utviklingen har for Norge. Det vektlegges at en ny global klimaavtale, EUs klima- og energipolitikk, og utviklingen til noen nøkkelaktører, og i regionale og globale energimarkeder vil være sentrale påvirkningsfaktorer for Norges politikkutforming fremover. Etterspørselen etter energi globalt vil øke i takt med befolkningsvekst og velstandsutvikling, samtidig som en omfattende omstilling i den globale energisektoren vil være nødvendig for å kutte klimagassutslipp. Vi finner at en viktig drivkraft i energiomstillingsprosesser er selvforsyning av energi. Store land og energimarkeder legger stadig større vekt på selvforsyning, noe som gir Norge som energiaktør både utfordringer og nye muligheter. Nyvinninger i fornybarteknologi og desentraliserte løsninger vil gjøre nye energiløsninger mulig både i industrialiserte land og i framvoksende økonomier. Dette vil ramme Norge som olje- og gasseksportør. Lave olje- og gasspriser skaper også utfordringer for Norge de nærmeste årene. Men endringene i verdens energimarkeder skaper også nye muligheter for Norge. Ved å være en godt forberedt og omstillingsklar energiaktør som kan levere teknologiske og finansielle løsninger til land som vil øke sitt energibehov samtidig som klimagassutslippene skal ned, kan Norge bidra med løsninger til energiomstillingsprosesser i andre land og gjennom internasjonalt samarbei

Wear and Migration of Highly Cross-Linked and Conventional Cemented Polyethylene Cups with Cobalt Chrome or Oxinium Femoral Heads: A Randomized Radiostereometric Study of 150 Patients

ABSTRACT: This randomized study was performed to compare wear and migration of five different cemented total hip joint articulations in 150 patients. The patients received either a Charnley femoral stem with a 22.2 mm head or a Spectron EF femoral stem with a 28 mm head. The Charnley articulated with a g-sterilized Charnley Ogee acetabular cup. The Spectron EF was used with either EtOsterilized non-cross-linked polyethylene (Reflection All-Poly) or highly cross-linked (Reflection All-Poly XLPE) cups, combined with either cobalt chrome (CoCr) or Oxinium femoral heads. The patients were followed with repeated RSA measurements for 2 years. After 2 years, the EtO-sterilized non-cross-linked Reflection All-Poly cups had more than four times higher proximal penetration than its highly cross-linked counterpart. Use of Oxinium femoral heads did not affect penetration at 2 years compared to heads made of CoCr. Further follow-up is needed to evaluate the benefits, if any, of Oxinium femoral heads in the clinical setting. The Charnley Ogee was not outperformed by the more recently introduced implants in our study. We conclude that this prostheses still represents a standard against which new implants can be measured. Osteolysis induced by wear debris of ultra-high molecular weight polyethylene (UHMWPE) is considered the most common cause for failure of total hip arthroplasties (THA). 1 Sterilization technique and UHMWPE quality are related to wear. 2 Sterilization with gamma irradiation in air breaks the polymer chains and generates free radicals. Free radicals may combine with each other creating cross-links between adjacent molecules, which reduces abrasive wear. However, they entail the disadvantage of oxidative degradation of polyethylene (PE) when exposed to the body&apos;s oxidative environment, which may lead to deterioration of mechanical properties. 3 To address the problem, sterilization methods in inert environments with ethylene oxide (EtO) or gas plasma were introduced. However, these methods do not have the benefits of cross-linking, and an earlier report showed increase in early in vivo wear after EtO sterilization. 4 Highly cross-linked polyethylenes (HXLPE) provides a considerable reduction of wear compared to conventional polyethylene (PE). Concerns of PE wear have also been addressed by introducing alternative femoral head materials. Oxidized zirconium (Oxinium, Smith &amp; Nephew) was introduced in the last decade for use in THA. Radiostereometric analysis (RSA) enables in vivo measurement of relative 3D motion in the range of 0.1 mm and 0.058. Due to its accuracy, few patients are needed to obtain satisfactory statistical power. With RSA the degree of migration during the first years after surgery correlates with the implant&apos;s longterm performance. We wanted to evaluate wear and migration patterns of the cemented highly cross-linked Reflection All-Poly XLPE cup and its non-irradiated counterpart, the cemented Reflection All-Poly cup, when articulating with either Oxinium or traditional cobalt chrome (CoCr) femoral heads (Smith &amp; Nephew). Our null hypothesis was that wear and migration were equal to the Charnley Ogee prostheses (DePuy Intl

A randomized study on migration of the Spectron EF and the Charnley flanged 40 cemented femoral components using radiostereometric analysis at 2 years

Background and purpose: We performed a randomized study to determine the migration patterns of the Spectron EF femoral stem and to compare them with those of the Charnley stem, which is regarded by many as the gold standard for comparison of implants due to its extensive documentation. Patients and methods: 150 patients with a mean age of 70 years were randomized, single-blinded, to receive either a cemented Charnley flanged 40 monoblock, stainless steel, vaquasheen surface femoral stem with a 22.2-mm head (n = 30) or a cemented Spectron EF modular, matte, straight, collared, cobalt-chrome femoral stem with a 28-mm femoral head and a roughened proximal third of the stem (n = 120). The patients were followed with repeated radiostereometric analysis for 2 years to assess migration. Results: At 2 years, stem retroversion was 2.3° and 0.7° (p < 0.001) and posterior translation was 0.44 mm and 0.17 mm (p = 0.002) for the Charnley group (n = 26) and the Spectron EF group (n = 74), respectively. Subsidence was 0.26 mm for the Charnley and 0.20 mm for the Spectron EF (p = 0.5). Interpretation: The Spectron EF femoral stem was more stable than the Charnley flanged 40 stem in our study when evaluated at 2 years. In a report from the Norwegian arthroplasty register, the Spectron EF stem had a higher revision rate due to aseptic loosening beyond 5 years than the Charnley. Initial stability is not invariably related to good long-term results. Our results emphasize the importance of prospective long-term follow-up of prosthetic implants in clinical trials and national registries and a stepwise introduction of implants

Antibiotic-loaded bone cement in prevention of periprosthetic joint infections in primary total knee arthroplasty: A register-based multicentre randomised controlled non-inferiority trial (ALBA trial)

Introduction The current evidence on the efficacy of antibiotic-loaded bone cement (ALBC) in reducing the risk of periprosthetic joint infections (PJI) after primary joint reconstruction is insufficient. In several European countries, the use of ALBC is routine practice unlike in the USA where ALBC use is not approved in low-risk patients. Therefore, we designed a double-blinded pragmatic multicentre register-based randomised controlled non-inferiority trial to investigate the effects of ALBC compared with plain bone cement in primary total knee arthroplasty (TKA). Methods and analysis A minimum of 9,172 patients undergoing full-cemented primary TKA will be recruited and equally randomised into the ALBC group and the plain bone cement group. This trial will be conducted in Norwegian hospitals that routinely perform cemented primary TKA. The primary outcome will be risk of revision surgery due to PJI at 1-year of follow-up. Secondary outcomes will be: risk of revision due to any reason including aseptic loosening at 1, 6, 10 and 20 years of follow-up; patient-related outcome measures like function, pain, satisfaction and health-related quality of life at 1, 6 and 10 years of follow-up; risk of changes in the microbial pattern and resistance profiles of organisms cultured in subsequent revisions at 1, 6, 10 and 20 years of follow-up; cost-effectiveness of routine ALBC versus plain bone cement use in primary TKA. We will use 1:1 randomisation with random permuted blocks and stratify by participating hospitals to randomise patients to receive ALBC or plain bone cement. Inclusion, randomisation and follow-up will be through the Norwegian Arthroplasty Register. Ethics and dissemination The trial was approved by the Western Norway Regional Committees on Medical and Health Research Ethics (reference number: 2019/751/REK vest) on 21 June 2019. The findings of this trial will be disseminated through peer-reviewed publications and conference presentations. Trial registration number NCT04135170.publishedVersio